Literature DB >> 1976166

Ketoconazole in treatment of visceral leishmaniasis.

J P Wali, P Aggarwal, U Gupta, S Saluja, S Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1976166     DOI： 10.1016/0140-6736(90)93272-q

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Kala-azar--new developments in diagnosis and treatment.

Authors:  P Aggarwal; R Handa; S Singh; J P Wali
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 3.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.

Authors:  J van Lunzen; P Kern; J Schmitz; J Brzoska; S Flessenkämper; M Dietrich
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

5.  MANAGEMENT OF KALA AZAR - AN UPDATE.

Authors:  S P Kalra; A Bahl; Lt Col Pc Sanchetee; S K Dham
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  β-Nitrostyrenes as Potential Anti-leishmanial Agents.

Authors:  Syed Shafi; Farhat Afrin; Mohammad Islamuddin; Garima Chouhan; Intzar Ali; Faatima Naaz; Kalicharan Sharma; Mohammad S Zaman
Journal:  Front Microbiol       Date:  2016-09-01       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.